Drug Type Gene therapy |
Synonyms PLX 400, PLX400 |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization Polaryx Therapeutics, Inc.Startup |
Active Organization Polaryx Therapeutics, Inc.Startup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Ceroid Lipofuscinosis, Neuronal, 2 | Preclinical | US | Polaryx Therapeutics, Inc.Startup | 21 Aug 2024 |